EULAR 2016

July 11, 2016July 11, 2016

Rheumatoid Arthritis Effectively Diagnosed and Treated with Biodegradable Nanoparticles in Early Study

News

Biodegradable polymer nanoparticles (BNPs), tiny particles made of a biodegradable polymer, appear to be quite useful for the early detection and for long-term, effective treatment of rheumatoid arthritis (RA) with minimal side effects, ... Read more

June 24, 2016June 24, 2016

Phase 3 Study Finds Oral Drug Reduces Joint Damage Caused by Rheumatoid Arthritis

News

Once daily treatment of moderate to severe rheumatoid arthritis with the oral drug baricitinib significantly reduced structural damage to patients’ joints, according to a study presented at the recent EULAR Annual Congress in London. Data for ... Read more

June 14, 2016June 14, 2016

#EULAR 2016 – Many Rheumatoid Arthritis Patients Experience Sexual Dysfunction

News

Colombian researchers have found that more than one third of patients with rheumatoid arthritis (RA) who are still sexually active have some type of sexual dysfunction. The results were recently presented ... Read more

June 14, 2016June 14, 2016

#EULAR 2016 – Repetitive Manual Work Can Increase a Person’s Risk of Developing RA

News

Researchers in Sweden report that long-term, repetitive manual work is associated with an increased risk for rheumatoid arthritis (RA). Their study, discussed at the recent European League Against Rheumatism Annual Congress (EULAR 2016) in London, is ... Read more

June 13, 2016June 13, 2016

#EULAR 2016 – Rheumatoid Arthritis Treatment Adherence Improved with Positive Expectations, Information

News

At the European League Against Rheumatism Annual Congress (EULAR 2016) June 8-11 in London, two new studies offered insights on why patients with rheumatoid arthritis (RA) do not adhere to their treatment ... Read more

June 13, 2016June 13, 2016

#EULAR 2016: UK Rheumatologists Often Prescribe Outside NICE Guidlines

News

A study presented at the European League Against Rheumatism Annual Congress (EULAR 2016) revealed that several factors not related to cost might influence the prescription of TNF inhibitors for patients with rheumatoid arthritis (RA). ... Read more

June 13, 2016June 13, 2016

#EULAR 2016 – Counseling and Reminders Help RA Patients to Be More Active

News

Behavioral interventions that combine text message reminders and counseling sessions to encourage rheumatoid arthritis patients to be more physically active lead to better clinical outcomes, according to a study presented ... Read more

June 10, 2016June 10, 2016

#EULAR2016 – Genetic Profiling Could Help Predict Response to Rheumatoid Arthritis Therapy

News

Genetic profiling could be used to predict whether or not patients with rheumatoid arthritis (RA) will respond to treatment, according to two new studies. The results were presented at the ... Read more

June 9, 2016June 9, 2016

#EULAR2016: Corrona Delivers Novel Research Evidence on Rheumatoid Arthritis

News

Southborough, Massachusetts-based Corrona LLC, independent specialists in the compilation of real-world evidence and consulting on auto-immune disorders, is represented at EULAR 2016 — the Annual European Congress of Rheumatology June 8-11 in ... Read more

June 6, 2016June 6, 2016

#EULAR2016 – AbbVie to Show New Data on RA Therapy Humira, Present Research on Drug Candidate ABT-494

News

AbbVie has announced that key data regarding Humira (adalimumab) will be presented at the Annual European Congress of Rheumatology (EULAR 2016) June 8-11 in London, England. The data includes investigational research along with ... Read more